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The paper is aimed to investigate the toxicity of nano-TiO2 and its potential harmful impact on human health using
meta-analysis of in vitro and short-time animal studies. Data were retrieved according to included and excluded
criteria from 1994 to 2011. The combined toxic effects of nano-TiO2 were calculated by the different endpoints by
cell and animal models. From analysis of the experimental studies, more than 50% showed positive statistical
significance except the apoptosis group, and the cytotoxicity was in a dose-dependent but was not clear in
size-dependent manner. Nano-TiO2 was detained in several important organs including the liver, spleen, kidney,
and brain after entering the blood through different exposure routes, but the coefficient of the target organs was
altered slightly from animal models. It is possible that nano-TiO2 can induce cell damage related to exposure size
and dose. Further studies will be needed to demonstrate that nanoparticles have toxic effects on human body,
especially in epidemiological studies.
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Background
Nanotechnology refers to a new set of technologies that
are used to develop nanoscale structures and devices
(typically between 1 and 100 nm at least in one dimen-
sion) with unique or enhanced properties utilized in
commercial applications [1]. Nanotechnology promises
to contribute much to the betterment of humanity, but
without appropriate assessment of the risks, the technol-
ogy will not be developed safely and with public confi-
dence [2]. Concern has been raised about the potential
impact of nanomaterials exposure on human health
[3,4]. A paper reported that a large number of workers
are potentially exposed to nanoparticles and the number
will be larger as nanotechnology develops and spreads in
Italy. Knowledge of exposure assessment shows that it is
very important to boost research in this field [5]. The
market may now face a growing number of downstream
users who are not informed about the type and content* Correspondence: tm@seu.edu.cn; wangbeilxb@gmail.com
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in any medium, provided the original work is pof NPs in the products they use. A 2009 survey indicates
that 80% of the workers’ representatives and 71% of the
employers’ representatives were not aware of the avail-
ability of nanomaterials and were ignorant as to whether
they actually use nanomaterials at their workplace [6]. If
an industrial material is identified as a harmful material,
the use may be restricted and the exposure may be
minimized by mandating protective clothing and
respirators.
Titanium dioxide (TiO2) is a widely used industrial
nanomaterial in things such as sunscreens, lacquers, and
paints [7]. The risk assessment of Nano-TiO2 should be
an integral part of modern society. So we consider the
following questions from a public health perspective:
what organs will detain nano-TiO2 by different ex-
posed routes, what effects do nano-TiO2 cause in the
body, and what is the biological mechanism driving
TiO2 nanoparticles toxicity? Epidemiologic studies form
an important link in understanding health outcomes
associated with exposures to potentially hazardous
materials [2]. Population-based studies about nano-TiO2
are few [8]; only a number of articles examining the
health risk of exposure to nano-TiO2 have been
published on the subject from animal and cell experi-
ment, but no coherent images can be achieved. Thus, an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Article selection flow chart.
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knowledge on the toxicity of nano-TiO2 by meta-
analysis.
Methods
Search strategy and inclusion criteria
The primary interest of this study is human health
effects exposed to nano-TiO2. Since there were no epi-
demiological studies on the subject, we have considered
experimental studies employing human cells, animals,
and animals cells as experimental units and exposing
them to nano-TiO2. The study articles must have definite
purpose, biological model, exposure time, exposure dose,
nano-TiO2 diameter (less than or equal to 100 nm), type of
endpoint measured, and main results. A comprehensive
literature search of several databases (pubmed, web of
science, CNKI, VIP, etc.) was conducted with combination
of relevant keywords, such as nano, titanium dioxide, health
effects, toxicity, mice, rat, experiment, human, stress, lactate
dehydrogenase, and enzyme kinetics. Only articles pub-
lished in English and Chinese were used. Abstracts and re-
view articles were not included.
Data extraction
From all the studies, we documented the following items
for the description of evidence: (a) biological model: the
category of studying cells or animals; the material char-
acter included physical and chemical properties espe-
cially diameter; (b) study design: exposure time, dose,
and routes of nano-TiO2 into the biological systems; and
(c) main results: the study endpoints from cell models
(cytotoxicity, enzyme activities, genotoxicity, apoptosis,
inflammation, etc.), and animal models (target organ, the
change of Ti detain and different organ coefficients etc.).
The data were extracted independently from each article
by two members of the research, and the discrepancies
in the information were resolved by consensus meetings.
Meta-analysis methods
Because of the great variety of the cell types or animal
species used and endpoints measured in different stud-
ies, calculation of a summary estimate of the effect size
was not possible. A very simple approach based on the
proportion of studies with positive findings from the
same endpoints was used. The studies were classified as
‘positive study’ (exposure to nano-TiO2 group had statis-
tical significance compared with the control group in
one of the endpoints) and ‘negative study’ (no statistical
significance). The analysis involved the percentage of
positive studies for categories according to various ex-
perimental characteristics. It is important to note that a
given study could be positive in one category, but nega-
tive in another category. A particular study could include
both positive and negative findings, if more than oneexperiment was performed with varying cell lines, exposure
schedules, etc., or if more than one biological endpoint was
measured. Analyses were made to examine whether the
percentage of positive studies was dependent on the
following: biological agent used, type of endpoint measured,




The electronic search resulted in 947 citations (Figure 1).
375 articles were selected after eliminating repeated
abstracts, review articles, and non-related topic articles.
After applying the inclusion criteria, 82 articles were
selected, retrieved, and read. Finally, 62 articles were
chosen for inclusion into the meta-analysis study.
Description of the evidence
One study included both cell and animal models, and
the description of evidence is documented in Table 1 (27
studies on cell models) and Table 2 (26 studies on mice
and rats) for the studies investigating the behavior of dif-
ferent biological model when exposed to nano-TiO2.
The toxicity of nano-TiO2 from vitro studies
The cultured cells exposed to toxic agents can respond
with various mechanisms that differ in the level of cell
damage. Nano-TiO2 has been studied mainly with
established in vitro toxicity assays that analyze major cel-
lular parameters such as cytotoxicity, enzyme activities,
genotoxicity, and response to various stress factors. Al-
though a variety of cell studies using nano-TiO2 has been
published so far, different articles may have no coherent
results. In this study, we calculated the percentage of posi-
tive studies with several of important endpoints. The over-
all percentage of positive studies differed very significantly
(p < 0.01) from the expected value of positive studies if
Table 1 Description of evidence for health effects of nano-TiO2 from cells models
Reference Biological model Diameter (nm) Time (h) Dose Main results
[9] U937 100 24~48 0.005~4 mg/ml Apoptotic and necrotic modifications
[10] A549 63 4~18 80 μg/ml DNA damage
[11] A549/NCI-H1299 20 24 0.3~1,000 μg/ml Aggregated
[12] CHO/293 T 10~60 24 25~325 μg/ml Genotoxicity
[13] BEAS-2B 5 24 100 μg/ml Increases cytokines IL-6 and IL-8
[14] HDF/A549 3.2~10 48 0.3~3,000 μg/ml Cytotoxicity and inflammation
[15] U973 20 12~24 0.625~20 μg/ml Transcriptional change of TIMP-1
[16] BGC-823 20 24~72 100~800 mg/L Cytotoxicity and inhibited growth
[17] NIH3 T3/HFW 15 24~72 0.0005~50 μg/ml Cytotoxicity and ROS
[18] WIL2-NS 8.2 6~48 26~130 μg/ml Cause genotoxicity and cytotoxicity
[19] PC12 cells 21 6~48 1~100 μg/ml ROS and apoptosis
[20] lymphocytes 25 1~48 20~100 μg/ml Induced genotoxicity
[21] MC3T3-E1 5/32 24~72 5~500 μg/ml Cytotoxicity and pro-inflammatory
[22] Hela cells 80 × 10 12 0.1~1.6 mg/ml Cytotoxicity and OS-mediated
[23] THP-1 cells 10 to 40 24 0.1~1.6 mg/ml Reactive oxygen
[24] HDMEC 70 24~72 5~50 μg/ml No cytotoxicity and inflammatory
[25] CHL 21 24/72 0.025~1.00 mg/ml Cytotoxicity
[26] HLF 21/80 24/48 5~80 mg/L Inhibit GJIC
[27] A549 5 to 10 6 25~200 μg/ml DNA damage
[28] Red cells 15 3 1.25~20.0 g/L MDA generations and hemolytic
[29] A549 25 1~24 100 μg/ml ROS and inhibit the growth
[30] BGC-823 20 24 0.1~0.4 mg/ml Increased ROS levels
[31] HaCaT 20 to 35 4 10~300 μg/ml Damaged structure and inhibited growth
[32] A549 5 24~72 5~160 μg/ml Induced ROS
[33] L929 20 to 100 24~72 50~200 μg/ml No cell proliferation and apoptosis
[34] 293 T and CHO 10 24 10~500 μg/ml Induced cell apoptosis
[35] HaCaT 4~60 24 10~200 mg/ml Cytotoxicity and apoptosis
BEAS, Human bronchial epithelial cells; CHL, Classical Hodgkin lymphoma; HDMEC, Human dermal microvascular endothelial cells; GJIC, Gap junctional intercellular
communication; HDL, human diploid fibroblast; HLF, Human lactoferrin; OS, Oxidative stress; NS, Nervous system; ROS, Reactive oxygen species.
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to show a p value less than 0.05 just by chance), suggesting
that we can reject the null hypothesis. According to
Tables 3, 4, 5, the total percentage of positive studies was
lower for studies on inflammation (25%) than for studies
on other endpoints, and the group of genotoxicity had a
highest percent positive result that reached 100% but
based on small numbers.
Cytotoxicity
Different endpoints for cytotoxicity have been used in
nanomaterials toxicity testing. Metabolic activity, for in-
stance, has been widely determined using the colorimet-
ric MTT assay based on the reduction of a yellow
tetrazolium dye (MTT) to a purple formation in the cells
bearing intact mitochondria. Cellular necrosis is another
endpoint commonly used in cell viability studies. Upon
necrosis, significant amounts of LDH is released fromthe cytosol and this LDH release can be easily detected
using INT (a yellow tetrazolin salt) as a substrate since
LDH catalyze its oxidation to a red formation [70].
Grouping of the cytotoxicity studies showed cytoxicity
in a dose-dependent manner and an inconspicuous
time-dependent relationship (Table 3). The percentage
of positive studies was more than 50% at over 0.005 mg/
ml and in all study times. Especially the group at 50 mg/
ml there were two positive studies from the papers, but
this is based on small numbers.Enzyme activities
Evidence is accumulating that enzyme activities induced by
nanomaterials is a key route by which these nanomaterials
induce cell damage. Our combined results clearly showed
that exposure to nano-TiO2 could induce the change of en-
zyme activities, and the percentage of the positive studies
Table 2 Description of evidence for health effects of nano-TiO2 from mice and rats models
Reference Exposed routes Diameter (nm) Dose Time Main results
[36] Digestive tract 25~155 5 g/kg 2 weeks Transported to other tissues and organs
[7] Respiratory tract 21 42 mg/m3 8 to 18 days Lung inflammation and neurobehavioral toxicity
[37] Respiratory tract 10/100 500 μg/mouse 30 days Pathological lesions in the brain and neurotoxicity.
[38] Intraperitoneal 5 5~150 mg/kg 14 days Liver toxicity, inflammation, and apoptosis
[39] Respiratory tract 25 1.25 mg 7 days Lung toxicities and presence of aggregates or agglomerates
[40] Skin 4/60 5% TiO2 60 days Retained in the stratum corneum and the basal cells
[41] Intraperitoneal 5 5~150 mg/kg 14 days Liver DNA cleavage and hepatocyte apoptosis
[42] Intraperitoneal 100 324~2592 mg/kg 7/14 days The toxicity of the liver, kidney, lung, and spleen
[43] Intraperitoneal 5 5~150 mg/kg 14 days Caused serious damage to the liver and kidney
[44] Respiratory tract <10 5~500 μg 24 h Induce lung inflammation
[45] Respiratory tract 34.8 550 μg/m3 4 h Do not induce lung inflammation
[46] Digestive tract 20 to 30 5 g/kg 14 days Liver and kidney toxicity
[47] Intraperitoneal 30 200~500 mg/kg 17 days Liver, kidney, and male productive toxicity
[25] Intraperitoneal 21 300 mg/kg 18 h Lung and liver damage
[48] Intraperitoneal 30 300 mg/kg 18 h/10 days No histopathological change in the tissue
[49] Intraperitoneal 20~40 4.876~120.7 mg/kg 14 days Liver damage
[50] Respiratory tract 25 1~10 mg/kg 10 days Lung damage
[51] Intraperitoneal 30 200~500 mg/kg 17 days Slight damages in the liver, kidney, and heart
[52] Digestive tract 20 to 30 5 g/kg 14 days Liver and kidney toxicity
[53] Respiratory tract 10 1,500 mg/m3 7~28 days Increased in pulmonary inflammation
[54] Caudal vein 20 to 100 0.1~0.8 mg/ml 5 days Induce DNA damage of the liver and kidney
[55] Digestive tract 4 5 g/kg 14 days No change in coefficients of the organs
[56] Intraperitoneal 6.9 5~150 mg/kg 14 days Induced kidney toxicity
[57] Respiratory tract 15 1~10 mg/kg 7~days Lung injury, changed the enzyme activities
[58] Caudal vein 5 0.24 μg/mouse 1~48 h Increase content of Ti in the liver, lung, and spleen
[59] Respiratory tract 80 - 1 month Distribution of Ti in the neural system
[60] Respiratory tract 50 0.5~50 mg/kg 7 days Induced oxidative stress in the liver and kidney
[61] Respiratory tract 20~30 3.5~17.5 mg/kg 5 weeks Lung damage, oxidative effects, inflammation
[62] Intraperitoneal 62 1~15 mg/kg 21 days Nephrotoxicity and tubular damages
[63] Respiratory tract 5 0.8~20 mg/kg 7 days Liver and lung damage
[64] Respiratory tract 5~10 0.4~40 mg/kg 7 days Changed enzyme activities
[65] Respiratory tract 25.1 2~50 mg/m3 5 days Enzyme activities and induced lung toxicity
[66] Respiratory tract 28.4 5 mg/kg 1 weeks Lung damage
[67] Respiratory tract 5 0.8~20 mg/kg 7 days Aggregate in the lung and kidney
[68] Respiratory tract 5, 21, 50 0.5~50 mg/kg 7 days Pulmonary toxicity
[69] Respiratory tract 20 to 30 3.5~17.5 mg/kg 5 weeks Immune system toxicity
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0.005mg/kg concentration. Overall, this results are based
on small numbers and further study needs to be done
(Table 3).
Genotoxicity
Evidence of genotoxicity has been previously researched
within a number of studies; micronuclei development isassociated with nano-TiO2 exposure, which is indicative
of chromosomal damage; DNA damage has also been
observed in response to nano-TiO2 exposure. The classic
comet assay based on gel electrophoresis and the detec-
tion of in vitro mammalian chromosomal aberrations
are the most commonly used test systems to assess
genotoxicity. A review describes knowledge about ge-
notoxicity investigations on nanomaterials published in
Table 3 Cytotoxicity and enzyme activities in different times and doses
Study dose
(mg/ml)
Cytotoxicitya (h) Enzyme activitiesa (h)
≤12 ≤24 ≤48 ≤72 Total Percentageb 0~6* 24* Total Percentageb
≤0.005 0/2 1/10 3/5 1/3 5/20 20 2/1 0/4 2/5 29
≤0.05 3/2 10/10 9/4 4/5 26/21 55 3/0 4/1 7/1 88
≤0.5 7/1 15/7 10/2 5/2 37/12 76 3/0 5/0 8/0 100
≤5 1/1 5/1 3/1 3/0 12/3 80 1/0 2/0 3/0 100
≤50 1/0/ 1/0 0/0 0/0 2/0 100 1/0 1/0 2/0 100
Total 12/6 32/28 25/12 13/10 82/56 59 10/1 12/5 22/6 79
Percentageb 67 53 68 57 - - 91 71 - -
aNumber of positive/negative studies.
bPercentage of positive studies.
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models [71]. In the following discussion, we focus on the
nano-TiO2 genotoxicity from the cell model with a dose
and time relationships, and all studies are positive based
on the results of a small number studies (Table 4).Apoptosis
Li et al. [72] revealed that there was the dose-dependent
effect of apoptosis in the N9 cells exposed to nano-TiO2
and the significant difference observed in 16 μg/ml TiO2
NPs-treated groups and this apoptosis might lead to the
dysfunction of microregions. The study of Carmen et al.
[10] reported that suspensions of TiO2 nanoparticles
prepared in U937 cells culture medium at concen-
trations that covered a range (0.005 to 4 mg/kg) induced
apoptosis in 24 and 48 h. In contrast, Han et al. [33]
results showed that the cell apoptosis was not influenced
by the presence of nano-TiO2 at 50 to 200 μg/ml for 24
to 72 h. Different studies have different results and in
this report on apoptosis, tests from cell models were
summarized and we calculated the combined effects of
exposure to nano-TiO2. According to Table 4, there is a
combined apoptosis effects at different times and
dosages and it gave us a clue for apoptosis induced by
exposure to nano-TiO2, although the number of studies
was small.Table 4 Genotoxicity and apoptosis in the different times and
Study hour Genotoxicitya (mg/ml)
≤0.05 ≤0.5 ≤0.005 ≤0.
≤6r 2/0 2/0 0/0 1/
≤24 3/0 5/0 1/0 2/3
≤48 4/0 4/0 1/0 1/3
Total 7/0 11/0 2/0 4/6
Percentageb 100 100 100 40
aNumber of positive/negative studies.
bPercentage of positive studies.Inflammation
To assess inflammation by nanomaterials immuno-
toxicity, the production of inflammatory markers such
as the chemokines interleukin (IL)-8, IL-6, or TNF-
.alpha; was usually measured in cell culture supernatants
using enzyme-linked immunosorbant assay. In this
study, we realized that the percentage of positive study is
lower and no dose- and time-dependent relationships
were found, and this may due to the small number of
studies available. Future studies determining inflamma-
tory combined effects of nano-TiO2 need go deep into
(Table 5) these aspects.Size dependency
Particle dimension is recognized as being fun-
damental to their toxicity. This derives from the fact that
NPs have been consistently demonstrated to be capable
of eliciting more pronounced toxicity than their large
(microparticulate) counterparts [73]. The size depend-
ency of nano-TiO2 toxicity has been frequently demon-
strated and appears to be applicable to a variety of
nano-TiO2 forms from the cell model. In this study, we
summarized the cytotoxicity of different nano-TiO2 di-
mension at 24 h, and we found that the percentage of
positive studies is higher at the 10 to 40 nm than other
groups (Table 5).doses
Apoptosisa (mg/ml)
05 ≤0.5 ≤5 ≤50 Total Percentageb
2/ 0/0 0/0 3/0 100
4/3 1/0 1/0 9/6 60
2/2 1/0 0/0 5/5 50
8/5 2/0 1/0 17/11 61
62 100 100 - -
Table 5 Inflammation and cytotoxicity in 24 h for the different doses
Study dose
(mg/ml)
Inflammationa (h) Cytotoxicity at 24 ha (nm)
≤24 ≤48 Total Percentageb <10 10 to 20 21 to 40 40 to 100 Total Percentageb
≤0.005 0/1 0/2 0/3 0 0/2 1/6 0/3 0/2 1/13 /7
≤0.05 0/1 0/2 0/3 0 0/3 7/3 4/2 0/2 11/10 52
≤0.5 1/1 1/1 2/2 50 2/2/ 5/2 5/2 0/2 12/8 60
≤5 0/0 1/1 1/1 50 0/0 3/1 1/1 1/0 5/2 71
Total 1/3 2/6 3/9 - 2/7 16/12 10/8 1/6 29/33 47
Percentageb 25 25 25 - 22 57 56 14 - -
aNumber of positive/negative studies.
bPercentage of positive studies.
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Contents of Ti and coefficients from different organs
After entering the blood by absorption or various
exposed route, nano-TiO2 was distributed to the import-
ant organs throughout the body. Distribution usually
occurs rapidly; the rate of distribution to organs or
tissues is determined primarily by blood flow and the
rate of diffusion out of the capillary bed into the cells of
a particular organ or tissue. In general, the initial phase
of distribution is dominated by blood flow, whereas the
eventual distribution is determined largely by affinity.
Understanding the distribution of nano-TiO2 in the
organs was the premise of studying toxicity and this will
provide direct evidence. We calculated the percentage
of positive studies based on different organs and time
(Table 6). Those results suggested that nano-TiO2
can be distributed in the important organs and it is pos-
sible to inducing body damage for biological systems.
Grouping of the studies of the spleen and brain revealed
that the percentage of positive studies was higher than
others. The contents of Ti in the heart are lower, but
this is based on small number of studies. In different
study times, every organ has a relatively higher content
of Ti and at 14 days it reaches at 81%. According to theTable 6 Contents of Ti and coefficients in the different organ
Study time (day) Livera Spleena Kidne
Contents of Ti ≤7 4/2 3/0 1/2
≤14 5/1 5/0 4/1
≤28 0/2 0/0 0/0
Total 9/5 8/0 5/3
Percentageb 64 100 63
Coefficient ≤7 0/1 0/0 0/1
≤14 9/13 2/10 4/10
≤28 0/2 0/2 0/2
Total 9/16 2/12 4/13
Percentageb 36 14 24
aNumber of positive/negative studies.
bPercentage of positive studies.results of Table 6, we further calculated the coefficients
of different organs and it showed that although exposure
to nano-TiO2 could increase deposition of Ti in different
organs, the coefficients of organs were changed slightly
(Table 6). We draw a conclusion that Ti detention may not
cause the change of coefficient of the targeted organs.The toxicity of nano-TiO2 from the study of different
exposed routes
Because exposure to nanoparticles can occur through in-
halation, skin contact, ingestion, and injection, studies
with biological model are the best possible appro-
ximation to exposure of the respiratory tract, skin,
gastrointestinal tract, intraperitoneal injection, or caudal
vein to nanomaterials. Studies found that exposure to
nano-TiO2 through different routes induced several
damages to the important organs, and the percentage of
the positive studies was calculated (Table 7). Results of
the combined effects showed that the positive percent-
age is higher in the exposure to nano-TiO2 in various
routes and the majority of the studies in the exposure to
nano-TiO2 group had statistical significance compared
with the control group.s
ya Lunga Braina Hearta Totala Percentageb
5/1 0/1 1/1 14/7 67
4/1 3/0 1/2 22/5 81
2/1 1/0 0/0 3/3 50
11/3 4/1 2/3 35 15
79 80 40 70 -
4/0 0/0 0/0 4/2 67
4/6 3/7 1/9 23/55 29
1/3 0/0 0/2 1/11 8
9/9 3/7 1/11 28/68 -
50 30 8 29 -
Table 7 Combined effects of nano-TiO2 on various organs
Exposed route Livera Spleena Kidneya Lunga Braina Hearta Totala Percentageb
Digestive tract 3/0 0/1 3/0 0/1 1/0 0/1 7/3 70
Respiratory tract 4/0 1/1 2/1 12/3 1/1 0/2 20/8 71
Intraperitoneal injection 7/2 1/1 5/1 2/2 1/0 2/1 18/7 72
Skin 1/0 1/0 1/0 1/0 0/1 0/1 4/2 67
Caudal vein 1/0 0/0 2/0 0/0 0/0 0/0 3/0 100
Totala 16/2 3/3 13/2 15/6 3/2 2/5 52/20 -
Percentageb 89 50 87 71 60 29 72 -
aNumber of positive/negative studies.
bPercentage of positive studies.
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Liver toxicity
The liver is the main organ where exogenous chemicals are
metabolized and eventually excreted. As a consequence, the
liver cells are exposed to significant concentrations of these
chemicals, which can result in liver dysfunction, cell injury,
and even organ failure. Eighteen studies found the toxicity
of nano-TiO2 in the liver from mice or rats, in vivo. The
findings from the studies [36,46,52] after oral exposure
suggested that nano-TiO2 could induce the damage to the
liver and pathologic examination showed that in the liver
tissue, the hydropic degeneration of the hepatocyte around
the central vein was found, with hepatocyte disorder, super-
ficial staining of cytoplasm osteoporosis. Tang et al. [67]
investigated the liver toxicity of nano-TiO2 subsequent to
the intratracheal instillation and indicated slight liver injury
and induced oxidative stress. But no coherent results
emerged, and so liver toxicity of the combined effects was
calculated when exposed to nano-TiO2. The percentage of
the positive studies is 89%, and it is very possible that ex-
posure to nano-TiO2 causes a liver toxicity (Table 7).Spleen toxicity
Immunotoxicology can be most simply defined as the
study of the adverse effects on the immune system
resulting from occupational, inadvertent, or therapeutic
exposure to drugs, environmental chemicals, and, in
some instances, biological materials. Studies in animals
and humans have indicated that the immune system
comprises potential target organs and that damage to
this system can be associated with morbidity and even
mortality. In this study, the spleen was chosen for
understanding immunotoxicology induced by nano-TiO2
and the contents of Ti in spleen had increased signifi-
cantly compared with the control group, but in the posi-
tive studies, the number of spleen coefficients was lower
than other groups by only 14%. In six studies, three
results showed nano-TiO2-induced spleen toxicity by
different exposure routes (Table 7).Kidney toxicity
The functional integrity of the mammalian kidney is vital
to the total body homeostasis, because the kidney plays
a principal role in the excretion of metabolic wastes and
in the regulation of extracellular fluid volume, electrolyte
composition, and acid–base balance. In this paper, we
found that there is an association between kidney tox-
icity and nano-TiO2 because the Ti content and positive
percentages are higher than other groups and the coeffi-
cient of kidney is relatively lower according to Table 6.
The results suggested that the kidney may be a main tar-
get organ of exposure to nano-TiO2 through different
routes into the body.Lung toxicity
Adverse health effects of air pollution have been
recognized in epidemiological studies, and it was found
that ultrafine particles have been linked with pulmonary
toxicity [74]. Here we focus on the pulmonary toxicity of
exposure to nano-TiO2. Published articles about lung
toxicity were obtained, and the available evidence
supports that the percentage of positive studies is higher
than other groups: 79% studies from the content of Ti in
lung (Table 6), 50% from coefficient of lung (Table 6),
and 71% from the combining effects by different expos-
ure routes (Table 7).Brain toxicity
Metal oxides have been extensively studied, because of
their toxic effects on humans and their utility in the study
of the nervous system (NS). For a review dedicated en-
tirely to the toxicity of metal oxides, the reader is referred
to [4,70,73]. In the following discussion, we focus on the
most important organ, the brain, in the nervous system
for nano-TiO2 exposure. Overall, the number of brain tox-
icity paper was very limited regarding the exposed nano-
TiO2 by various routes. Four studies suggested that the
contents of Ti increased at different exposure time
(Table 6) and the coefficient of brain changed slightly
(Table 6). According to Table 7, the results illustrated that
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is only based on a small number of studies.
Heart toxicity
Cardiovascular toxicology is concerned with the adverse
effects of extrinsic and intrinsic stresses on the heart
and vascular system. A limited number of studies have
been conducted to determine the impact of nano-TiO2
particles within in vivo models of heart toxicity. How-
ever, the findings suggest that nano-TiO2 through differ-
ent exposure routes is deposited in the heart and
contribute to inflammatory response and change in the
enzyme activities which leads to heart toxicity. Grouping
of the studies with heart toxicity revealed that the per-
centage of positive studies was lower than other groups
about Ti content, coefficient, and combined effects by
different routes (Tables 6 and 7).
Conclusion and discussion
Evaluating the hazards associated with nano-TiO2 is
vital for risk assessments. Numerous articles from ex-
periments have been reported in the literature on the re-
lationship between exposure to nano-TiO2 and health
consequences, but no coherent results have emerged
from different articles. To reveal possible consistent
patterns, 62 papers were collected and the data was
analyzed by systematic comparison of the study charac-
teristics between positive and negative studies. This
paper provides a few clues for the hypothesis that nano-
TiO2 has an impact on health in humans.
Cultured cells exposed to nano-TiO2 can respond to
various mechanisms that differ in the level of cell dam-
age, and we accumulated 27 studies from cell models on
the relationship between nano-TiO2 and biological sys-
tem toxicity. Based on the different endpoints, we
calculated the combined toxic effects of exposure to
nano-TiO2. The results suggested that the percentage of
positive studies is more than 50%, except in the apop-
totic group. The cytotoxicity was dose-dependent but
not clearly size-dependent. We summarized that the
cytotoxicity of different nano-TiO2 dimensions at 24 h
and the percentage of positive studies is higher at the 10
to 40 nm than other groups. It is possible that nano-TiO
2 causes cell damage related to the size and dose in dif-
ferent endpoints. Exposure to toxins can occur through
inhalation, skin contact, ingestion, and injection; and we
found that different exposure routes can lead to the
higher percentage of positive studies from vivo study.
After entering the blood by absorption or various expos-
ure routes, nano-TiO2 was detained in the several import-
ant organs such as the liver, spleen, kidney, and brain, but
the coefficient of target organ was changed slightly. The
liver and kidney have a high capacity for binding many
chemicals. These two organs probably concentrate moretoxicants than all the other organs combined, and in most
cases, active transport or binding to tissue components
are likely to be involved. In our study, we also found that
the liver and kidney had a higher percentage of positive
studies when exposed to nano-TiO2.
Standard problems related to meta-analytic approaches,
including publication bias, variable quality, and un-
recognized confounding, might have affected our results.
We also recognize that our study has a possible bias.
Firstly, the limitation of this meta-analysis stems from the
languages chosen. Secondly, our conclusions could be
biased due to the fact that positive results obtained from
experiments with identical experimental design to those
with negative results are not published finally. Another
reason for bias in our study is the fact that the articles
included in this meta-analysis were only from in vitro or
animal experiment. Despite these limitations, to our know-
ledge, this meta-analysis represents the largest and most
comprehensive effort to assess the safety of nano-TiO2.
At the nanometer scale, certain materials exhibited
new properties that do not exhibit in macroscale. These
new size-dependent properties of nanomaterials repre-
sent both the promise of nanotechnology and the con-
cern about the potential adverse health effects on
workers, consumers, and environment. Epidemiologic
studies have the potential to be quite valuable in deter-
mining links between different types of occupational ex-
posure to nanomaterials and the development of health
problems. In addition, if properly designed, these studies
could provide the ability to identify adverse health
outcomes much earlier than if not conducted. However,
the lessons learned from the studies of other particulates
(e.g., asbestos and fine particulates in air) suggested that
early attention to the health effects in the context of
epidemiologic studies should be considered as soon as
possible [8]. In order to take preventive measures, re-
duce and eliminate adverse effects on health, and pro-
vide a theoretical basis for the safety evaluation of
nanomaterials, further research should consider epi-
demiological study to explore the association between
nanomaterials and health effects.
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